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Introduction
Genetic counseling of mosaic trisomy at amniocentesis is
difficult because of the phenotypic variability associated
with the condition; some fetuses exhibit the typical
phenotype, while others are normal [1–3]. Trisomy 7
mosaicism has variable and nonspecific clinical fea-
tures [4–8]. Most patients with trisomy 7 mosaicism
have a normal karyotype in blood lymphocytes, but
mosaic trisomy 7 in fibroblasts derived from the skin
show pigment abnormalities. Trisomy 7 mosaicism at
amniocentesis has been reported to be associated
with maternal uniparental disomy for chromosome 7
(UPD 7) and Silver-Russell syndrome (SRS) [9–11].
Here, we report the prenatal diagnosis and molecular
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SUMMARY
Objective: To present prenatal diagnosis and molecular genetic analyses of mosaic trisomy 7.
Materials, Methods and Results: A 38-year-old primigravid woman underwent amniocentesis at 19 weeks of 
gestation because of her advanced maternal age. Amniocentesis revealed a karyotype of 47,XY,+7[26]/46,
XY[16]. Repeated amniocentesis at 21 weeks of gestation revealed a karyotype of 47,XY,+7[20]/46,XY[17].
Simultaneous cordocentesis revealed a karyotype of 46,XY in 100/100 cultured lymphocytes. Polymorphic DNA
marker analyses of uncultured amniocytes and cord blood revealed a diallelic pattern with seemingly equal
biparental inheritance of chromosome 7. Repeated cordocentesis and chorionic villus sampling at 23 weeks of
gestation revealed a karyotype of 47,XY,+7[2]/46,XY[66] in cord blood and a karyotype of 47,XY,+7 in 24/24
cultured chorionic villi cells. Level II ultrasonography was normal. At 40 weeks of gestation, a 2,708 g normal
male baby was delivered. The peripheral blood had a karyotype of 46,XY in 100/100 lymphocytes. Molecular
analyses of placenta, urine, buccal swab, and peripheral blood revealed a diallelic pattern and seemingly equal
biparental inheritance of chromosome 7 in all tissues. At 3 months of age, he manifested hypopigmented skin
and inguinal hernia, but showed normal growth and mental development. Fluorescence in situ hybridization
analysis of inguinal hernia sac tissue revealed that 19/100 (19%) of nuclei had three chromosome 7 signals.
Conclusion: Mosaic trisomy 7 at amniocentesis may be derived from a cell culture artifact from an undetected
low level of trisomy 7 mosaicism in uncultured amniocytes, and can be associated with favorable fetal outcome
if the blood has a normal karyotype or a very low level of mosaicism and if uniparental disomy for chromosome
7 is excluded. [Taiwan J Obstet Gynecol 2010;49(3):333–340]
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genetic analyses of mosaic trisomy 7 at amniocentesis
in a pregnancy with a favorable fetal outcome.
Materials, Methods and Results
A 38-year-old primigravid woman underwent amnio-
centesis at Mackay Memorial Hospital at 19 weeks 
of gestation because of her advanced maternal age.
The woman had suffered from bilateral tubal occlu-
sion and primary infertility. This was her first preg-
nancy that was conceived by in vitro fertilization and
embryo transfer. Four embryos had been implanted
and three survived. The triplet pregnancy had three
gestational sacs. At 7 weeks of gestation, fetal demise
occurred in two fetuses. The remaining singleton fetus
developed well at the time of amniocentesis.
In 26 of 42 separated amniocyte colonies, an
abnormal karyotype of 47,XY,+7 was found (Figure 1),
while the other 16 colonies had a karyotype of 46,XY.
The cytogenetic result of amniocentesis was 47,XY,+7
[26]/46,XY[16]. The parental karyotypes were normal.
Repeated amniocentesis at 21 weeks of gestation
revealed 47,XY,+7[20]/46,XY[17]. Simultaneous cord
blood sampling revealed a karyotype of 46,XY in
100/100 cultured lymphocytes. Polymorphic DNA
marker analysis of the cord blood and uncultured
amniocytes using microsatellite markers specific for
chromosome 7 revealed a biparental inheritance of chro-
mosome 7. There was a diallelic pattern and seemingly
equal biparental inheritance of chromosome 7 in the
cord blood and uncultured amniocytes (Figure 2). The
molecular result excluded UPD 7.
At 23 weeks of gestation, the woman underwent
repeated cord blood sampling and chorionic villus
sampling at National Taiwan University Hospital.
Cytogenetic analyses showed that the cord blood lym-
phocytes had a karyotype of 47,XY,+7[2]/46,XY[66],
and the chorionic villi had a karyotype of 47,XY,+7 in
24/24 cultured chorionic villi cells. A methylation-
specific polymerase chain reaction (PCR) assay was
performed to identify the differential methylation of
the imprinted PEG1/MEST locus on 7q32 and revealed
biparental inheritance of chromosome 7 in the cord
blood and chorionic villi (Figure 3). Polymorphic DNA
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Figure 1. Karyotype of 47,XY,+7.
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Figure 2. Representative electrophoretograms of quantita-
tive fluorescent polymerase chain reaction assays at short
tandem-repeat markers specific for chromosome 7. The
marker D7S2201 shows two peaks (108 and 112 bp; mater-
nal and paternal) of seemingly equal fluorescent activity
from two different parental alleles in uncultured amniocytes
from the amniotic fluid sample and cord blood. The marker
D7S1809 also shows two peaks (212 and 224 bp; paternal and
maternal, respectively) of seemingly equal fluorescent activity
from two different parental alleles. AF = amniotic fluid.
marker analysis of the chorionic villi cells revealed a
diallelic pattern with unequal biparental inheritance of
chromosome 7 with a dosage ratio of 1:2 (paternal
allele:maternal allele) (Figure 4).
Level II obstetric ultrasonography revealed normal
fetal growth biometry, a normal fetal craniofacial profile,
and no structural abnormalities. The parents decided
to continue the pregnancy. At 40 weeks of gestation, a
2,708 g male baby was delivered uneventfully at Mackay
Memorial Hospital. The baby was normal without pig-
ment abnormalities of the skin. Cytogenetic analysis of
the peripheral blood lymphocytes (100 cells) of the
neonate revealed a karyotype of 46,XY. Polymorphic
DNA marker analyses of placenta, urine, buccal swab,
and peripheral blood cells of the neonate revealed a dial-
lelic pattern with seemingly equal biparental inheri-
tance of chromosome 7 in all tissues examined (Figure 5).
At a routine pediatric follow-up examination at 
3 months of age, the infant showed normal growth and
mental development. He manifested hypopigmented
skin on both thighs and underwent herniorrhaphy for
inguinal hernia. Fluorescence in situ hybridization
(FISH) analysis in the pathological specimen of the
inguinal hernia sac tissue revealed that 19/100 (19%)
of nuclei had three chromosome 7 signals indicating
mosaic trisomy 7 in the inguinal hernia sac tissue.
Discussion
The present case provides evidence for a discrepancy
between the cytogenetic results of cultured amniocytes
and the molecular results of uncultured amniocytes in
mosaic trisomy 7 at amniocentesis. The high level of
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Figure 3. Polymerase chain reaction (PCR) products from bisulfite-modified DNA, using an unmethylated allele-specific
primer pair and a methylated allele-specific primer pair on the methylation-sensitive high resolution melting PCR assay. 
(A) a normal subject with the wild-type methylated and unmethylated alleles; (B) a subject with maternal uniparental disomy
of chromosome 7 with only the methylated allele; (C) cord blood; (D) chorionic villi.
trisomy 7 in cultured amniocytes might be derived from
a cell culture artifact from an undetected low level of
trisomy 7 mosaicism in the uncultured amniocytes. In
the present case, although various tissues presented a
diallelic pattern with seemingly equal biparental inher-
itance of chromosome 7, a very low level of trisomy 7
mosaicism cannot be completely excluded.
The quantitative fluorescent polymerase chain reac-
tion (QF-PCR) assay shows limitations for the detec-
tion of very low levels of chromosomal mosaicism. The
QF-PCR assay can detect mosaicism when the abnormal
cell line contributes at least 15% of the whole sample
[12]. In a cohort study performed to detect mosaicism
of primary trisomies in prenatal samples by QF-PCR
and karyotype analysis, Donaghue et al [12] found that
the QF-PCR assay detected mosaicism when a meioti-
cally derived abnormal cell line contributed 15% of the
genotype, but mitotically derived mosaicism might not
be detected at this low level.
At least 13 cases of mosaic trisomy 7 detected at
amniocentesis have been reported (Table). The
reported fractions of trisomy 7 cells or colonies range
from 5% to 78%. Among those cases, nine had a normal
phenotype and four had phenotypic abnormalities, of
which two were associated with maternal UPD 7 and
SRS [9–11]. Maternal UPD 7 is the mostly frequently
reported UPD, second to UPD 15. Maternal UPD 7 is
characterized by pre- and postnatal growth retarda-
tion, relative macrocephaly, micrognathia, a high
arched palate, down-turned corners of the mouth, a
triangular facial shape, and neuropsychological devel-
opmental delay [16,17]. Paternal UPD 7 is rare, and
only three cases have been reported to date [18–20].
Paternal UPD 7 has been reported in several autoso-
mal recessive disorders such as chloride diarrhea, cys-
tic fibrosis, complete situs inversus, and immotile cilia.
Paternal UPD 7 can be associated with developmental
delay and overgrowth [20]. Maternal complete isodis-
omy 7 should be the result of a post-zygotic mitotic
segregation error, whereas maternal heterodisomy 7
should be the result of trisomic rescue after a meiotic
non-disjunction event at the first meiotic cell division
[21,22].
SRS (OMIM 180860) is characterized by severe
intrauterine growth restriction (IUGR), poor postnatal
growth, craniofacial features of a triangular-shaped face
with a broad forehead, down-turned corners of the
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Figure 4. Representative electrophoretograms of quantitative
fluorescent polymerase chain raction assays at short tandem-
repeat markers specific for chromosome 7. The marker
D7S1809 shows two peaks (212 and 224 bp; paternal and
maternal) of unequal fluorescent activity from two different
parental alleles. The dosage ratio was 1:2 in cultured chorionic
villi cells. The markers D7S3051 and D7S2201 also show a dial-
lelic pattern with a dosage ratio of 1:2 (paternal:maternal).
The results are consistent with trisomy 7 of maternal origin.
CVS = chorionic villus sampling.
Figure 5. Representative electrophoretograms of quantitative
fluorescent polymerase chain reaction assays at short tandem-
repeat markers specific for chromosome 7. The marker
D7S2201 shows two peaks (108 and 112 bp; maternal and
paternal) of seemingly equal fluorescent activity from two
different parental alleles in placenta, urine, buccal swab, and
peripheral blood cells. The marker D7S1809 also shows a
diallelic pattern with seemingly equal fluorescent activity
from two different parental alleles.
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mouth, a small mandible, prominent ears, fifth finger
clinodactyly, asymmetry of the face, body and limbs,
occasional genital anomalies, and café-au-lait spots
[23]. Imprinting defects on 11p such as epimutations
in 11p15 imprinting center region 1 represents 30% of
the cases with SRS, and maternal UPD 7 represents
about 5% of the cases with SRS [24,25]. Prenatal diag-
nosis of mosaic trisomy 7 should raise suspicion of
UPD 7, although UPD 7 associated with prenatally
diagnosed mosaicism is thought to be rare [26].
Prenatal diagnosis of UPD 7 can be achieved by
QF-PCR by genotyping the fetus and the parents with
microsatellite markers to identify the loss of one parental
contribution, or with methylation-specific PCR [27–29].
Polymorphic DNA marker analysis requires samples
from both parents and multiple polymorphic specific
loci, whereas the methylation-specific PCR assay can
specifically distinguish maternal and paternal alleles,
and identify the differential methylation of the imprinted
PEG1/MEST locus without requiring parental samples.
The human PEG1/MEST gene is an imprinted gene on
chromosome 7q32. PEG1/MEST is expressed from the
paternal allele but not from the maternal allele [30].
Kaneko-Ishino et al [31] designated it as PEG1
(paternally expressed gene 1) because of its paternal
expression, and Sado et al [32] referred to it as 
MEST (mesoderm-specific transcript) because of its
predominant expression in the mesoderm and its
derivatives.
The assessment of DNA methylation at specific sites
can be performed by bisulfite treatment of DNA or by
digestion with methylation-sensitive restriction enzymes.
In CpG methylation, a methyl group can be attached 
to a cytosine base located at 5 to guanosine. After bisul-
fite treatment, sodium bisulfite converts unmethylated
cytosine to uracil, whereas methylated cytosine in 
the CpG dinucleotide is resistant to this chemical modifi-
cation.
Flori et al [11] suggested that SRS patients with
maternal UPD 7 might also result from an undetected
low level of trisomy 7 mosaicism. SRS is well known to
present with IUGR, short stature and limb asymmetry
on prenatal ultrasound [33–35]. Accordingly, prenatal
diagnosis of mosaic trisomy 7 at amniocentesis should
include detailed sonographic investigation of IUGR,
short stature and asymmetry, and a molecular genetic
analysis of UPD 7 in the cord blood.
In conclusion, mosaic trisomy 7 at amniocentesis
may be derived from a cell culture artifact from an unde-
tected low level of trisomy 7 mosaicism in the uncultured
amniocytes, and can be associated with favorable fetal
outcomes if the blood has a normal karyotype or a
very low level of mosaicism and if UPD 7 is excluded.
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